1. Introduction
Iron-sulfur (Fe-S) clusters are essential cofactors found in a wide variety of proteins across all domains of life. These clusters consist of iron and sulfur ions with different compositions, structures, redox states, and coordination ligands in proteins. The most frequently found clusters are the rhombic [2Fe-2S] and the cubic or cubane [4Fe-4S], but [3Fe-4S] and [4Fe-3S] clusters have also been described. The chemistry of these clusters makes them ideal for sensing redox signals, as they can accommodate different electronic configurations by accepting or donating unpaired electrons. Consequently, these clusters serve a wide spectrum of functions within proteins, including electron transfer, enzymatic catalysis, protein structural stability, cofactor transfer, oxygen and iron sensing, as well as redox stress [
1]. These functions render Fe-S proteins crucial roles in multiple cellular processes, including energy production, metabolite transformation, DNA maintenance, gene expression regulation, protein synthesis, mitosis, and antiviral defense [
2].
In the early stages of identifying and characterizing Fe-S clusters in the human proteome, the proteins discovered were primarily associated with mitochondrial and cytosolic functions, such as ferredoxins, aconitases, and respiratory complexes [
3]. When the first Fe-S cluster bound to a helicase was reported in 2006, the authors stated “
Fe-S clusters are rare in nuclear proteins” [
4]. Nearly two decades later, we see that this perspective has completely changed, with the nucleus now known to contain about 35 proteins that bind Fe-S clusters, turning the nuclear compartment into a hot spot for Fe-S-related processes. The inventory of nuclear Fe-S cluster binding proteins described to date is listed in
Table 1.
The link between iron metabolism and nucleic acid metabolism is becoming increasingly clear. This is evident in processes related to genome integrity, with Fe-S clusters found in many proteins involved in DNA replication and repair, as well as in transcription, with Fe-S clusters present in RNA polymerase, transcription factors, and RNA modification proteins. Although the precise role of these Fe-S clusters often remains elusive, their prevalence in proteins associated to nucleic acid transactions, and the fact that they have not been replaced by less redox-active metals throughout evolution, suggest that they play a crucial role in nucleic acid metabolism.
In this review, we discuss the current knowledge of nuclear Fe-S cluster proteins, examine accumulating evidence suggesting that Fe-S clusters may have additional and unexpected roles in cells, and highlight areas of research that may have practical significance but for which no definitive evidence has yet emerged.
2. Metallation of Nuclear Fe-S Cluster Proteins
The assembly of Fe-S clusters in mammalian cells involves a complex interplay between two machineries: the mitochondrial Iron-Sulfur Cluster (ISC) pathway and the Cytosolic Iron-Sulfur Assembly (CIA) pathway. This organized, multistep process relies on the functions of multiple proteins located inside and outside the mitochondria and consists of common underlying mechanisms of cluster synthesis, trafficking, and insertion into the final recipient proteins. Cofactor maturation of the nuclear [4Fe-4S] proteins depends on the function of both the ISC and the CIA pathways, as evidenced by the defects in the metallation of nuclear Fe-S proteins when depleting either ISC or CIA components [
11,
65,
73,
74,
75,
76,
77,
78,
79]. Excellent recent reviews have focused on the known aspects of the
de novo assembly of clusters inside and outside the mitochondria [
2,
80,
81]. Although numerous studies in yeast and mammalian cells indicate that mitochondria provide the raw materials for the
de novo assembly of clusters, studies in mammalian cells suggest that
de novo assembly of Fe-S clusters also occurs in the cytosol via a dual localization of some ISC components in the mitochondria and the cytosol [
66,
68,
82,
83,
84]. However, the relative contribution of each pathway to the assembly of clusters in mammalian cells remains unclear.
Similarly, the source of the iron used for the assembly of clusters has not been determined. In the cytosol, the iron chaperone poly C-binding protein 1 (PCBP1) binds iron from the kinetically labile, exchangeable iron pool (called the labile iron pool) and delivers it to ferritin and non-heme iron enzymes [
85,
86,
87,
88]. The co-chaperone complex comprised of PCBP1 and BOLA2, formed via a bridging Fe ligand, serves as an intermediate for the assembly of [2Fe-2S] clusters on the chaperone complex formed by BOLA2 and the monothiol glutaredoxin GLRX3 [
89]. In mitochondria, however, the source of iron for cluster assembly is still an open question due to the lack of known iron chaperones residing in the mitochondrial compartment. Although some early studies suggested that frataxin could act as the mitochondrial iron donor for the ISC [
90,
91,
92,
93], mounting evidence does not support an iron chaperone function for frataxin, but instead indicates a role as an allosteric activator of the persulfide transfer process during the initial steps of Fe-S cluster assembly [
81,
94,
95]. Consequently, the source of iron for mitochondrial ISC-mediated cluster synthesis remains unknown.
A fully assembled Fe-S cluster may be transferred to a recipient apoprotein that requires the cluster for function. This associative transfer occurs via protein-protein interactions, which protect the labile cofactor from chemical attack during delivery and prevent the cofactor from engaging in harmful redox chemistry. More than one system may be involved in the transfer of clusters to recipient apoproteins. The insertion of Fe-S clusters into apoproteins is facilitated by chaperone proteins such as HSC20 [
82,
84] or co-chaperone systems of the CIA-targeting complex (CTC), composed of three proteins: CIAO1, MMS19, and FAM96B/CIAO2B [
74,
77,
78,
96,
97]. To assist the incorporation of Fe-S clusters into target proteins, HSC20 recognizes target proteins containing a short peptide (LYR) motif [
82]. In contrast, the CTC guides the Fe-S clusters from the CIA to client apoproteins containing a conserved [LIM]-[DES]-[WF] C-terminal tripeptide motif, called the CTC recognition motif, which facilitates the identification of about a quarter of the known CTC clients or their adaptors [
98]. However, this C-terminal signature is only present in a handful of the known Fe-S cluster-binding proteins (
Table 1). It is still unclear how the apo-client recognition occurs for the remaining 75% of the Fe-S cluster proteins that do not contain the described CTC recognition motif. Alternative recognition motifs and new adaptor proteins mediating cluster transfer from CTC to apoproteins are likely yet to be discovered.
It is broadly assumed that Fe-S clusters are inserted into client apoproteins during protein synthesis and folding in the cytosol and remain bound during the lifetime of the Fe-S cluster protein. This seems necessary for proteins in which the cluster is buried deeply within the tertiary structure of the protein. For example, xanthine oxidase (XDH) contains 2 Fe-S clusters buried in the interior of the protein. The free exchange of these clusters seems unlikely due to steric hindrance inherent in the structure of the folded protein (
Figure 1A). However, evidence is lacking that shows Fe-S metallation steps must occur exclusively during folding in the cytosol and before the nuclear protein is translocated to the nucleus. An additional hypothesis points to the possibility of cluster transfer after full translation and folding of the apoproteins. Two interesting observations may shed light in this regard: the evidence of Fe-S cluster transfer via adaptor-mediated protein-protein interactions [
98], and the presence of multiple CIA components in the nucleus of the cell.
First, emerging evidence suggests that a subset of Fe-S proteins require an adaptor protein for their recognition by the CTC [
98,
99]. This is the case for the DNA primase subunit 2 (PRIM2) with its adaptor PRIM1, the elongator subunit ELP3 with its adaptor ELP4, and the ribosome recycling factor ABCE1 with its adaptor LTO1 [
98,
99]. These three [4Fe-4S] cluster proteins receive clusters from the CTC but do not contain the C-terminal [LIM]-[DES]-[WF] CTC recognition motif in their sequences. Instead, the CTC recognition motif is present in the C-terminus of the corresponding adaptor proteins [
98]. This suggests that the transfer of the metalloclusters through adaptor-mediated protein-protein interactions should occur once the proteins have been synthesized and folded, and the client-adaptor complexes have been formed. Supporting this idea, the PRIM2/PRIM1 complex appears to form prior to Fe-S cluster incorporation into PRIM2 [
100]. Both PRIM2 and PRIM1, while in complex, directly interact with the CIA targeting complex for cluster transfer [
101]. This may only be possible for proteins harboring readily accessible, solvent-exposed cluster binding sites.
Figure 1B-D shows that the three proteins, ABCE1, PRIM2, and ELP3, that use an adaptor protein for CTC recruitment have, in fact, solvent-exposed clusters. Thus, it is probable that the CTC donates cofactors to fully- or partially folded proteins with accessible cluster binding sites, while proteins with buried clusters may utilize a co-translational system that delivers clusters during protein folding. Further studies are needed to clarify how this parallel process occurs.
Although solvent-exposed clusters are inherently more susceptible to oxidative damage [
104,
105,
106,
107] and may require replacement or repair to maintain their function, proteins with exposed clusters may also exchange cofactors more readily. This lability could confer to these proteins the capacity to sense and respond to environmental cues. For example, the variable metallation status of the iron-responsive protein 1 (IRP1/ACO1) [
108], the nuclear receptor coactivator 4 (NCOA4) [
109], or the F-box and leucine-rich repeat protein 5 (FBXL5) [
50], determine the biological activity of these three proteins. They are central to the regulation of intracellular iron metabolism and Fe-S cluster binding allows for coordination of the intracellular iron supply with their cellular activities. These three proteins also harbor solvent-exposed clusters. However, it remains to be demonstrated whether other Fe-S proteins, including nuclear Fe-S enzymes with solvent-exposed cluster binding sites, may exist as a pool of fully folded proteins that incorporate the cluster only when required to respond to cellular needs. Interestingly, although most of the proteins involved in the assembly and delivery of clusters are present in the cytosol, the nucleus of the cell also houses many of them including, MMS19 [
21,
110], CIAPIN1 [
56], CIAO1 [
110], CIAO2B [
21], GLRX3 [
62], NFU1 [
66], NFS1 [
68], NUBP2 [
63], GLRX2 [
71], and PCBP1 [
5]. Whether these proteins assist in the
in-situ transfer of iron or Fe-S clusters to client proteins in the nucleus remains elusive.
4. Fe-S Cluster Proteins in Mitosis
Once DNA is fully replicated, cells enter mitosis following an intricate and highly regulated process that ensures each new cell receives an exact copy of the genetic blueprint. It has long been established that MMS19 and CIA2B localize to the mitotic spindle during mitosis and that their knockdown disrupts the mitotic pathway, leading to poor alignment of chromosomes, improper segregation, accumulation of nuclei with abnormal shapes, and mislocalization of key mitotic factors [
21]. However, it was only a few years ago that a mitotic factor was identified as binding an Fe-S cluster. The chromokinesins KIF4A, which is involved in faithful chromosome segregation during mitosis, binds an Fe-S cluster [
45] (
Figure 2D). Molecular motor kinesins are the primary source of cellular forces and drive many types of intracellular movement along microtubule networks. KIF4A and KIF4B are the two variants of the kinesin family 4 present in humans. They share 98% homology in their DNA sequence with different chromosomal location [
218]. This ATP-dependent microtubule-based motor kinesin resides in the nucleoplasm during interphase and on the arms of condensed chromosomes during mitosis. KIF4A accumulates at the central spindle that connects the two daughter cells during the late stages of mitosis, from late anaphase through cytokinesis [
44,
219,
220]. This stabilizes the bipolar mitotic spindle, which is essential for successful midzone formation and cytokinesis. In KIF4-deficient cells, the central spindle becomes disorganized, leading to cytokinesis failure [
221,
222], chromosome misalignment, spindle defects, and chromosome missegregation. This results in shorter and wider chromosomes, lagging chromosomes, aneuploidy, and ultimately tumor formation [
220,
223].
Unlike other motor kinesins, KIF4A resides in the nucleus during interphase where it performs additional non-mitotic functions. KIF4A has been proposed to play a role in the DNA damage response by modulating the BRCA2/Rad51 pathway. Its C-terminal cargo-binding domain interacts with the conserved C-terminal region of BRCA2, facilitating the translocation of BRCA2 to damaged DNA regions following injury [
224]. Depletion of KIF4A results in a significant slowdown of DNA replication and decreased homologous recombination [
224]. KIF4 also acts as a modulator of large-scale chromatin architecture. It binds globally to chromatin and its depletion leads to chromatin decondensation and loss of heterochromatin domains [
223]. Overall, KIF4 deficiency has been associated with developmental delays and intellectual disabilities [
225] and it is abnormally expressed in multiple cancers [
218]. KIF4A has been also implicated in the infection process of Hepatitis B and D viruses by regulating the transport of the NTCP receptor from the cytoplasm to the cell surface, where it functions as a receptor for viral entry [
218,
226].
Structurally speaking, KIF4A features a highly conserved ATPase/motor domain at the N-terminus that binds to microtubules and provides the mechanochemical force for movement. This is followed by a central α-helical stalk domain and a C-terminal cargo-docking domain responsible for capturing cargoes [
227,
228]. The [4Fe-4S] cluster in KIF4A is bound to a conserved cysteine-rich domain located at the C-terminus [
45]. However, it remains unclear which of the nine conserved Cys residues located in that region coordinate the Fe-S cluster. Whether the cluster is redox-active is also unknown.
In mitotic cells, KIF4A colocalizes with the CIA components CIAO2B and MMS19 at the spindle midzone and midbody between separating chromosomes [
45] (
Figure 2D). KIF4A also co-immunoprecipitates with CIAO2B and MMS19, confirming their physical interaction [
45]. This interaction is enhanced after iron chelation, suggesting a more stable association between the CIA complex and the apo client protein [
45]. Similar enhancements in interactions between CIA and client proteins under iron deprived conditions has been observed for other Fe-S proteins, including XPD, FANCJ, and Pol δ [
78]. The mislocalization of the KIF4A variant lacking the conserved C-terminal cysteine domain that binds the cluster, along with the reduced association of endogenous KIF4A with the midzone/midbody following CIAO3 depletion, suggests that the Fe-S cluster in KIF4A modulates the proper subcellular localization of the protein at the mitotic spindle. This likely influences the protein-protein interactions essential for the mitotic process [
45].
Although the cluster in KIF4A is quite labile in [
55]Fe radiolabeling experiments, its absence does not appear to affect the stability of the protein [
45], as seen for other Fe-S cluster binding proteins. This dynamic nature may be biologically relevant and allow for the assembly and disassembly of the Fe-S cluster in KIF4A to regulate the progression of mitosis [
45], which could explain why the late-acting CIA factors colocalize at the midbody with components of the mitotic machinery. This suggests that the cluster is transferred to a folded client protein at the site of function, rather than co-translationally transferred. Further mechanistic studies are needed to elucidate the role of the Fe-S cluster in modulating KIF4A activity and whether the metallation of KIF4A occurs only after the breakdown of the nuclear membrane when cells enter mitosis, or if KIF4A residing in the nucleus during interphase also binds an Fe-S cluster.
KIF4A and KIF4B are currently the only known components of the mitotic machinery that bind an Fe-S cluster. However, the significant mitotic defects observed when silencing the CIA, along with the colocalization of late-acting CIA factors with components of the mitotic machinery, suggest the potential existence of other, yet-to-be-discovered Fe-S cluster proteins that are essential for successful mitosis.
6. Conclusions and Open Questions
About half of all known Fe-S binding proteins in human cells localize to the nucleus, with many identified only recently. A few decades ago, the presence of iron cofactors in the nucleus was considered unlikely due to the threat that the reactive iron poses to the genetic material. However, chaperoning and trafficking systems that safely mobilize these cofactors facilitate their incorporation in DNA metabolic enzymes, leveraging their redox capabilities while minimizing risks. The connection between iron cofactors and genome integrity is now well established, with an increasing number of nuclear Fe-S proteins, particularly those involved in nucleic acid metabolism such as DNA replication and repair. The high metabolic expense associated with incorporating clusters into proteins suggest that they play essential roles. However, the mechanistic benefit of incorporating Fe-S clusters into nucleic acid-binding proteins remains unclear. Mismetallation of these nuclear Fe-S cluster enzymes often leads to genome instability, which is linked to various diseases, including breast and ovarian cancer, Fanconi anemia, Xeroderma pigmentosum, and the Cockayne, Warsaw breakage and Hoyeraal-Hreidarsson syndromes.
Most nuclear Fe-S cluster proteins bind cubane [4Fe-4S] clusters using a canonical four-cysteinyl ligand structure. A few exceptions exhibit alternative architectures for cluster binding sites and stoichiometries, including the [2Fe-2S] proteins CPSF4 and FBXL5, the [3Fe-4S] protein NCOA4, and the radical SAM enzymes that bind the [4Fe-4S] cluster using three cysteines and an exchangeable S-adenosyl-L-methionine. In some cases, such as CPSF4 and KIF4A/B, the exact residues responsible for cluster binding have yet to be determined.
There is clear evidence that most nuclear Fe-S proteins depend on the CIA machinery for their metallation. However, a systematic survey of the specific CIA subcomplexes and adaptors required for the metallation of each nuclear Fe-S protein is necessary to fully understand how, when, and where Fe-S proteins acquire their clusters, as well as how this process is regulated. Notably, nuclear Fe-S proteins appear to bind the clusters at solvent-exposed loops. New evidence suggests that cluster transfer can occur to fully folded proteins forming complexes. Investigation of newly obtained structures of Fe-S proteins would help us understand whether solvent accessible clusters are a general characteristic of [4Fe-4S] proteins and if this has functional implications. One can speculate that these accessible positions may allow for sensory roles of the clusters, enabling dynamic cluster disassembly and reassembly in response to intracellular cues like redox status or iron levels, thus allowing cells to modulate Fe-S enzyme activity according to their needs. Do solvent-accessible, redox-active clusters play a role in sensing structural changes in DNA, e. g. DNA damage? [
229] The possibility of re-metallation or repair of exchangeable clusters for reactivating
apo proteins raises important questions about the dynamic trafficking of bioavailable Fe-S clusters and whether an equilibrium exists between the
apo and
holo forms of these proteins. Trafficking systems, such as the Glrx3-[2Fe-2S]-BolA2 system that exchanges Fe-S clusters with nuclear iron-responsive transcriptional regulators in fungi, may also traffic a pool of bioavailable Fe-S clusters in the nucleus of mammalian cells. Alternatively, CIA targeting complexes may deliver clusters
in-situ when and where needed, as observed for the mitotic factor KIF4A, which colocalizes with MMS19 at the mitotic spindle. All these hypotheses remain to be experimentally tested.
The discovery of Fe-S clusters in viral proteins, including the SARS-CoV-2 RNA-dependent RNA polymerase [
128] and the helicase nsp13 [
127], as well as the hepatitis B virus protein HBx, which localizes to the nucleus of mammalian cells during infection [
230,
231], indicates a broad role for Fe-S clusters in viral infection. It seems likely that additional nuclear Fe-S binding proteins will be identified, particularly among those automatically annotated in the proteome as Zn-binding proteins. We hope this review encourage further research on the unresolved questions regarding Fe-S clusters in human cells, potentially leading to promising avenues for the development of novel therapeutic strategies.